SCHEMBL10879477

SCHEMBL10879477

CC(=O)N(C)c1cc(Br)c(N=C2NCCN2)c(Br)c1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10876477 0.82 FSCN1 (0.36) SMN1; SMN2
SCHEMBL10880907 0.81 SRD5A1 (0.32) SMN1; SMN2
SCHEMBL10876831 0.75 LMNA (0.40) SMN1; SMN2
SCHEMBL10879541 0.72 ALOX5 (0.34)
SCHEMBL10879424 0.72 TSHR (0.38) SMN1; SMN2
SCHEMBL10879537 0.68 ACHE (0.30)
SCHEMBL10878250 0.68 ADRA2A (0.31)
Hydrochloric Acid SCHEMBL11004812 0.67 GAA (0.38)
SCHEMBL11020813 0.67
Hydrochloric Acid SCHEMBL11019924 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0081924-B1 TOPICAL COMPOSTIONS FOR LOWERING INTRAOCULAR PRESSURE ALCON LABORATORIES, INC. (US) 1986-02-19 EP disclosed
US-4517199-A TREATMENT OF GLAUCOMA ALCON LABORATORIES, INC. (US) 1985-05-14 US disclosed
US-4515800-A GLAUCOMA ALCON MANUFACTURING, LTD. 1985-05-07 US disclosed